Athersys Inc (ATHXQ)

[Will77506]

Hahaha
It's a double blinded study, so wouldn't have heard anything anyway. That and without combining all the data it would be hard to tell if an individual improved because of the stem cells or if he just improved naturally. In other words you can't tell anything from 1 or 2 individuals. In addition to the CEO seeing the 1 and 2 cohorts blinded data and then attempting to push forward as quickly as possible. Most of the subjects were dosed with the stem cells, so I am assuming the overall blinded data showed above average improvement.

Athersys is ahead of all the other stem cell companies for the stroke trial , so I highly double other stem cell companies will get approval first.

Not saying this will work, but try to back up your reasoning.